Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ATAZANAVIR for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 169 adverse event reports in the FDA FAERS database where ATAZANAVIR was used for Maternal exposure timing unspecified.

Most Reported Side Effects for ATAZANAVIR

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 903 16.6% 82 76
Drug interaction 730 13.4% 153 151
Maternal exposure during pregnancy 653 12.0% 7 43
Depression 590 10.9% 152 125
Exposure during pregnancy 295 5.4% 3 15
Abortion spontaneous 275 5.1% 1 9
Premature baby 256 4.7% 26 26
Virologic failure 201 3.7% 5 12
Loss of personal independence in daily activities 167 3.1% 57 28
Premature delivery 159 2.9% 0 14
Live birth 158 2.9% 0 23
Anxiety 147 2.7% 13 133
Hyperbilirubinaemia 140 2.6% 1 27
Nausea 136 2.5% 3 47
Suicidal ideation 134 2.5% 13 126

Other Indications for ATAZANAVIR

Hiv infection (3,272) Product used for unknown indication (1,073) Antiretroviral therapy (419) Acquired immunodeficiency syndrome (69) Prophylaxis against hiv infection (50) Hiv test positive (31) Covid-19 (29) Acute hiv infection (25) Hepatitis c (18) Perinatal hiv infection (18)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) DARUNAVIR ETHANOLATE (154)

Related Pages

ATAZANAVIR Full Profile All Maternal exposure timing unspecified Drugs ATAZANAVIR Demographics ATAZANAVIR Timeline